Filing Details
- Accession Number:
- 0000899243-19-027733
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-20 20:02:40
- Reporting Period:
- 2019-11-18
- Accepted Time:
- 2019-11-20 20:02:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1399529 | Dicerna Pharmaceuticals Inc | DRNA | Pharmaceutical Preparations (2834) | 205993609 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1598480 | B James Weissman | C/O Dicerna Pharmaceuticals, Inc. 33 Hayden Avenue Lexington MA 02421 | Evp & Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-18 | 20,000 | $3.42 | 34,704 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-18 | 20,000 | $22.00 | 14,704 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-11-19 | 20,000 | $3.42 | 34,704 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-19 | 20,000 | $24.00 | 14,704 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-11-18 | 20,000 | $0.00 | 20,000 | $3.42 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-11-19 | 20,000 | $0.00 | 20,000 | $3.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | 2023-09-24 | No | 4 | M | Direct | |
| 0 | 2023-09-24 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2018.
- This option vested 1/48 monthly on the last day of each month with a vesting start date of 7/30/2013.
Billionaire Hedge Funds
